Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 1/2017

01-01-2017 | Review Article

No-touch isolation techniques for pancreatic cancer

Authors: Tamotsu Kuroki, Susumu Eguchi

Published in: Surgery Today | Issue 1/2017

Login to get access

Abstract

The rate of recurrence, including liver metastasis is high in pancreatic cancer, even when complete surgical resection is performed as a curative treatment. In patients with pancreatic cancer, the handling and grasping of the pancreas during surgery may increase the risk of liver metastasis, as squeezing may spread cancer cells via the portal vein. A no-touch isolation technique might prevent the spread of cancer cells via the hematogenous metastatic route in patients with pancreatic cancer. However, while no-touch isolation techniques are simple, feasible and, in theory, ideal procedures for the surgical treatment of pancreatic cancer, there have been no randomized controlled prospective studies to validate their advantages and their efficacy remains controversial. It is, therefore, worth investigating the use of no-touch isolation techniques in pancreatic cancer.
Literature
1.
Andrén-Sandberg Å, Neoptolemos JP. Resection for pancreatic cancer in the new millennium. Pancreatology. 2002;2:431–9.CrossRefPubMed
2.
3.
Michalski CW, Kleeff J, Wente MN, Diner MK, Büchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007;94:265–73.CrossRefPubMed
4.
Yokoyama Y, Nimura Y, Nagino M. Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies. Surg Today. 2009;39:466–75.CrossRefPubMed
5.
Malleo G, Marchegiani G, Salvia R, Butturini G, Pederzoli P, Bassi C. Pancreaticoduodenectomy for pancreatic cancer: the Verona experience. Surg Today. 2011;41:463–70.CrossRefPubMed
6.
Iwagami Y, Eguchi H, Wada H, Tomimaru Y, Hama N, Kawamoto K, et al. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer. Surg Today. 2015;45:444–50.CrossRefPubMed
7.
8.
Yamaue H, Tani M, Onishi J, Kinoshita H, Nakamori M, Yokoyama S, et al. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas. 2002;25:366–72.CrossRefPubMed
9.
Beger HG, Rau B, Gansauge F, Poch B, Link KH. Treatment of pancreatic cancer: challenge of the facts. World J Surg. 2003;27:1075–84.CrossRefPubMed
10.
Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol. 2006;12:4466–72.CrossRefPubMedPubMedCentral
11.
Nentwich MF, Bockhorn M, König A, Izbicki JR, Cataldegirmen G. Surgery for advanced and metastatic pancreatic cancer: current state and trends. Anticancer Res. 2012;32:1999–2002.PubMed
12.
Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg. 1967;166:420–5.CrossRefPubMedPubMedCentral
13.
Wiggers T, Jeekel J, Arends JW, Brinkhorst AP, Kluck HM, Luyk CL, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg. 1988;75:409–15.CrossRefPubMed
14.
Fujita J, Uyama I, Sugioka A, Komori Y, Matsui H, Hasumi A. Laparoscopic right hemicolectomy with radical lymph node dissection using the no-touch isolation technique for advanced colon cancer. Surg Today. 2001;31:93–6.CrossRefPubMed
15.
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–91.CrossRefPubMed
16.
17.
Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol. 2012;30:525–32.CrossRefPubMed
18.
Tjensvoll K, Nordgård O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Int J Cancer. 2014;134:1–8.CrossRefPubMed
19.
Yap TA, Lorente D, Omlin A, Olmos D, de Bono JS. Circulating tumor cells: a multifunctional biomarker. 2014;20:2553–68.
20.
Kulasinghe A, Perry C, Jovanovic L, Nelson C, Punyadeera C. Circulating tumor cells in metastatic head and neck cancers. Int J Cancer. 2015;136:2515–23.CrossRefPubMed
21.
Soeth E, Grigoleit U, Moellmann B, Röder C, Schniewind B, Kremer B, et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol. 2005;131:669–76.CrossRefPubMed
22.
Kurihara T, Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Tsuji S, et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg. 2008;15:189–95.CrossRefPubMed
23.
Bidard FC, Huguet F, Louvet C, Mineur L, Bouché O, Chibaudel B, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 2013;24:2057–61.CrossRefPubMed
24.
Hoffmann K, Kemer C, Wilfert W, Mueller M, Thiery J, Hauss J, et al. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow, and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol. 2007;13:257–63.CrossRefPubMedPubMedCentral
25.
Sergeant G, Roskams T, van Pelt J, Houtmeyers F, Aerts R, Topal B. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer. 2011;11:47. doi:10.​1186/​1471-2407-11-47.CrossRefPubMedPubMedCentral
26.
Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. HepatoGastroenterol. 1993;40:426–9.
27.
Kobayashi S, Asano T, Ochiai T. A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. HepatoGastroenterol. 2001;48:372–4.
28.
Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010;199:e65–8.CrossRefPubMed
29.
Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg. 2012;99:1027–35.CrossRefPubMed
30.
Hirota M, Shimada S, Yamamoto K, Tanaka E, Sugita H, Egami H, et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP. 2005;6:143–51.PubMed
31.
Gall TMH, Jacob J, Frampton AE, Krell J, Kyriakides C, Castellano L. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg. 2014;149:482–5.CrossRefPubMed
32.
Hirota M, Hashimoto D, Ishiko T, Satoh N, Takamori H, Chikamoto A, et al. Distal pancreatectomy using a no-touch isolation technique. Scand J Surg. 2012;101:156–9.CrossRefPubMed
33.
Strasberg SM, Drebin JA, Linehan DC. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521–7.CrossRefPubMed
34.
Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204:244–9.CrossRefPubMed
35.
Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC, Strasberg SM. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg. 2012;214:46–52.CrossRefPubMed
36.
Park HJ, You DD, Choi DW, Heo JS, Choi SH. Role of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. World J Surg. 2014;38:186–93.CrossRefPubMed
37.
Kitagawa H, Tajima H, Nakagawara H, Makino S, Miyashita T, Terakawa H, et al. A modification of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the left pancreas: significance of en bloc resection including the anterior renal fascia. World J Surg. 2014;38:2448–54.CrossRefPubMedPubMedCentral
38.
Kooby DA, Hawkins WG, Schmidt CM, Weber SM, Bentrem DJ, Gillespie TW, et al. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg. 2010;210:779–85.CrossRefPubMed
39.
Rehman S, John SK, Lochan R, Jaques BC, Manas DM, Charnley RM, et al. Oncological feasibility of laparoscopic distal pancreatectomy for adenocarcinoma: a single-institution comparative study. World J Surg. 2014;38:476–83.CrossRefPubMed
40.
Kuroki T, Eguchi S. Laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma. Surg Today. 2015;45:808–12.CrossRefPubMed
41.
Lee SH, Kang CM, Hwang HK, Choi SH, Lee WJ, Chi HS. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc. 2014;28:2848–55.CrossRefPubMed
Metadata
Title
No-touch isolation techniques for pancreatic cancer
Authors
Tamotsu Kuroki
Susumu Eguchi
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Surgery Today / Issue 1/2017
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-016-1317-5

Other articles of this Issue 1/2017

Surgery Today 1/2017 Go to the issue

Original Article

Modified Marcy repair for indirect inguinal hernia in children: a 24-year single-center experience of 6826 pediatric patients

Original Article

Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution

Original Article

Regeneration of peritoneal mesothelial cells after placement of hyaluronate carboxymethyl-cellulose (Seprafilm®)

Short Communication

Duodenal-jejunal bypass changes the composition of the gut microbiota

Original Article

Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis

Original Article

Expression of BRCA1, a factor closely associated with relapse-free survival, in patients who underwent neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil for squamous cell carcinoma of the esophagus